E-FABP could act on tumor microenvironment through the upregulation of VEGF34, the increase of MMP9 to provide an invasive phenotype35 and the stimulation of cancer progression and metastasis through the epithelial-mesenchymal transition process36. This evidence concerns the gene MMP9 and neoplasm.